drugset / Trial / NCT03046836

Oxytocin, Alcohol Craving, and Intimate Partner Aggression

NCT03046836 ↗

Phase 2 Completed 200 enrolled Medical University of South Carolina
RandomizedParallel-groupDouble-blindTreatment

Summary

Alcohol use disorders (AUD) and intimate partner aggression (IPA) frequently co-occur. There are significant health and economic burdens associated with AUD and co-occurring IPA, and little empirical data to guide treatment efforts. The neuropeptide oxytocin may help mitigate both AUD and IPA. However, clinical data examining oxytocin's effects on human aggression is scant. The proposed study is designed to address these gaps in the literature by utilizing a human laboratory paradigm to test the effects of oxytocin on craving and aggression among couples with AUD and co-occurring IPA.

Timeline

Start
2017-07-01
Primary completion
2021-04-11
Completion
2021-04-11

Outcome

Missed primary endpoint

paper No group differences emerged in alcohol consumption, alcohol problem severity, or relationship functioning at end of treatment. PMID 40392716 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide 40 iu Intranasal